Ethambutol

Ethambutol Reactions 1704, p159 - 2 Jun 2018 Amblyopia: case report A 70-year-old man developed amblyopia following treatment with ethambutol [route, dosage, duration of treatment to time to reaction onset not stated]. The man was diagnosed with tuberculosis on 24 September 2015 and started receiving treatment with isoniazid, rifampicin, pyrazinamide and ethambutol. Before the initiation of the treatment, he reported of left eye blurred vision, and his right eye (cataract) had vision of 20/70 and normal colour discrimination. He reported of blurred vision deterioration on 5 January 2016. On 7 January 2016, he was diagnosed with degenerative glaucoma. On 18 January 2016, he underwent operation for cataract in his right eye. However, he reported abnormal colour discrimination on 26 January 2016. The man’s tuberculosis treatment was discontinued on 30 January 2016 [outcome not stated]. Author comment: "[Ethambutol] related blurred vision is most likely to be confused with degenerative diseases in the elderly." Ji Y-J, et al. Experience sharing of amblyopia caused by EMB drugs in regional hospitals. International Journal of Antimicrobial Agents 50 (Suppl. 2): S252-S253, Nov 2017 [abstract] - Taiwan 803323303 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Ethambutol

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/ethambutol-P0Q8TiLcfe
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46802-8
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p159 - 2 Jun 2018 Amblyopia: case report A 70-year-old man developed amblyopia following treatment with ethambutol [route, dosage, duration of treatment to time to reaction onset not stated]. The man was diagnosed with tuberculosis on 24 September 2015 and started receiving treatment with isoniazid, rifampicin, pyrazinamide and ethambutol. Before the initiation of the treatment, he reported of left eye blurred vision, and his right eye (cataract) had vision of 20/70 and normal colour discrimination. He reported of blurred vision deterioration on 5 January 2016. On 7 January 2016, he was diagnosed with degenerative glaucoma. On 18 January 2016, he underwent operation for cataract in his right eye. However, he reported abnormal colour discrimination on 26 January 2016. The man’s tuberculosis treatment was discontinued on 30 January 2016 [outcome not stated]. Author comment: "[Ethambutol] related blurred vision is most likely to be confused with degenerative diseases in the elderly." Ji Y-J, et al. Experience sharing of amblyopia caused by EMB drugs in regional hospitals. International Journal of Antimicrobial Agents 50 (Suppl. 2): S252-S253, Nov 2017 [abstract] - Taiwan 803323303 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off